Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of Molecular Pathology in the Treatment of Anaplastic Gliomas and Glioblastomas.

Journal of the National Comprehensive Cancer Network : JNCCN - 1 May 2018

Holdhoff Matthias

Abstract excerpt

The 2016 WHO Classification of Tumors of the Central Nervous System integrated molecular biomarkers into the classifications of malignant gliomas. Several markers now play a key role in our understanding of these tumors and are integral for clinical decision-making; these include codeletion of 1p and 19q and IDH1 and IDH2 mutations. The presentation by Matthias Holdhoff, MD, PhD, at the NCCN 23rd Annual...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Alkylating
Share to Chromosomes, Human, Pair 19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Decision-Making

Share to Medical Oncology

Share to Oligodendroglioma

Share to Palliative Care

Share to Societies, Medical

Share to Temozolomide

Source

Identifiers

PMID: 29784746
DOI: 10.6004/jnccn.2018.0045

Genes

IDH1
IDH2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of Molecular Pathology in the Treatment of Anaplastic Gliomas and Glioblastomas.PMID 29784746Read ↗

Molecular biology of high-grade gliomas: what should the clinician know?Semantic proximity Read ↗

[How molecular biology can improve the clinical diagnosis of gliomas?]Semantic proximity Read ↗

Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.Semantic proximity Read ↗

[World Health Organization Classification of Central Nervous System Tumours, 5th Edition:Points of the Update and the Current Status].Semantic proximity Read ↗

Molecular Pathology of Gliomas.Semantic proximity Read ↗

Molecular Pathology of Gliomas.Semantic proximity Read ↗

Anaplastic Astrocytoma: State of the art and future directions.Semantic proximity Read ↗

Incorporating Advances in Molecular Pathology Into Brain Tumor DiagnosticsSemantic proximity Read ↗

[Basic principles of diagnosis and treatment of gliomas].Semantic proximity Read ↗

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.Semantic proximity Read ↗

Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.Semantic proximity Read ↗

2016 World Health Organization Classification of Central Nervous System Tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.